DNAzyme targeting EBV-LMP1 (DZ1)

N/A

Report date: 2025/12/16 20:00:07
NME

Base Information

Drug NameDNAzyme targeting EBV-LMP1 (DZ1)
Drug Alias NameDZ1
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionLatent membrane protein 1 modulators
TargetsLatent membrane protein 1
Therapy Area/IndicationsNasopharyngeal Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaPending
Originator CompaniesXiangya Hospital Of Central South University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXiangya Hospital Of Central South University
Active IndicationsN/A
Inactive IndicationsNasopharyngeal Carcinoma

Other Information

ATC CodeN/A
Related LinksN/A